ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
84.295
0.41%
US Dollar vs AUD
1.51293
0.14%
Bitcoin
63,220.78
0.27%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) News

ACET

Adicet Bio (ACET)

Adicet Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACET
DateTimeSourceHeadlineSymbolCompany
07/05/202421:00Business WireAdicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:ACETAdicet Bio Inc
01/05/202407:10Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
23/04/202406:30Business WireAdicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:ACETAdicet Bio Inc
08/04/202421:00Business WireAdicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
29/03/202408:19Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
20/03/202407:10Business WireAdicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:ACETAdicet Bio Inc
11/03/202422:00Business WireAdicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:ACETAdicet Bio Inc
01/03/202411:46Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
06/02/202408:01Business WireAdicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:ACETAdicet Bio Inc
03/02/202403:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACETAdicet Bio Inc
01/02/202408:39Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
27/01/202411:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
27/01/202411:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
26/01/202408:01Business WireAdicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ACETAdicet Bio Inc
25/01/202408:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
25/01/202408:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACETAdicet Bio Inc
23/01/202415:43Business WireAdicet Bio, Inc. Announces Pricing of Public OfferingNASDAQ:ACETAdicet Bio Inc
23/01/202408:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACETAdicet Bio Inc
23/01/202408:28Business WireAdicet Bio, Inc. Announces Proposed Public OfferingNASDAQ:ACETAdicet Bio Inc
20/01/202408:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACETAdicet Bio Inc
16/01/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
04/01/202423:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
04/01/202423:00Business WireAdicet Provides Corporate Update and Highlights Strategic Priorities for 2024NASDAQ:ACETAdicet Bio Inc
04/01/202408:01Business WireAdicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate OutlookNASDAQ:ACETAdicet Bio Inc
30/12/202308:50Business WireAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
11/12/202304:00Business WireAdicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:ACETAdicet Bio Inc
14/11/202308:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
09/11/202308:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACETAdicet Bio Inc
09/11/202308:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
09/11/202308:10Business WireAdicet Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
 Showing the most relevant articles for your search:NASDAQ:ACET

Your Recent History

FX
EURAUD
Euro vs AUD
ASX
TLS
Telstra
ASX
WPL
Woodside Petroleum
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
ASX
XAO
Australian SE All Ordina...
COIN
ETHUSD
Ethereum
FTSE
UKX
FTSE 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
MQG
Macquarie
ASX
XJO
S&P ASX 200
NYSE
NKE
Nike
ASX
XFL
S&P ASX 50
ASX
NAB
National Australia Bank
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved